Imperial Innovations builds healthcare and technology ventures based on intellectual property developed at or associated with the UK's four leading universities.
Bringing valuable ideas to market
Innovations was founded in 1986 as the technology transfer office of Imperial College London and was admitted to the AIM of the London Stock Exchange in 2006. Until 2011, Innovations invested only in companies based on intellectual property developed at Imperial College. In January of that year, the company raised £140 million to invest in businesses built on intellectual property developed at or associated with the Universities of Cambridge and Oxford and University College London, in addition to Imperial College London.
Since admission to AIM in 2006, we have raised over £200 million to invest in and grow technology and healthcare businesses based on pioneering academic research. In 2013, we received a £30 million loan facility from the European Investment Bank to fund healthcare ventures. We have invested over £143 million in this time, and our portfolio of companies has raised over £470 million.
Innovations' portfolio made good progress during 2013: Oxford Immunotec listed on NASDAQ under the symbol OXFD and IXICO gained admission to the AIM of the London Stock Exchange, under the symbol IXI.
We can provide financing from pre-company formation through all stages of development, including leading later stage rounds. We prefer to be engaged at the earliest possible opportunity, based on our deeply held belief that leading companies begin life with the right financial backers supporting them from their inception.